Centocor Denied Summary Judgment on Remicade Injury Claims

CLEVELAND - A federal judge has denied Centocor Ortho Biotech Inc.'s motion for summary judgment on Remicade injury claims, finding an issue of fact as to whether the drug's label warned of the risk of Remicade-induced non-infectious lung disease. DeGidio v. Centocor Ortho Biotech Inc., No. 09-721 (N.D. Ohio).

On Nov. 5, Judge James G. Carr of the U.S. District Court for the Northern District of Ohio further ruled that the learned intermediary doctrine does not bar the plaintiff's claims.

Anthony DeGidio received four Remicade infusions between April and August 2007 to treat his Crohn's disease. In 2007, DeGidio developed …